Matches in Wikidata for { <http://www.wikidata.org/entity/Q74509064> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q74509064 description "artículu científicu espublizáu n'abril de 1998" @default.
- Q74509064 description "im April 1998 veröffentlichter wissenschaftlicher Artikel" @default.
- Q74509064 description "scientific article published on 01 April 1998" @default.
- Q74509064 description "wetenschappelijk artikel" @default.
- Q74509064 description "наукова стаття, опублікована у квітні 1998" @default.
- Q74509064 name "[Development of anti-cancer drugs under new renewed GCP--from the viewpoint of drug development company developer]" @default.
- Q74509064 name "[Development of anti-cancer drugs under new renewed GCP--from the viewpoint of drug development company developer]" @default.
- Q74509064 type Item @default.
- Q74509064 label "[Development of anti-cancer drugs under new renewed GCP--from the viewpoint of drug development company developer]" @default.
- Q74509064 label "[Development of anti-cancer drugs under new renewed GCP--from the viewpoint of drug development company developer]" @default.
- Q74509064 prefLabel "[Development of anti-cancer drugs under new renewed GCP--from the viewpoint of drug development company developer]" @default.
- Q74509064 prefLabel "[Development of anti-cancer drugs under new renewed GCP--from the viewpoint of drug development company developer]" @default.
- Q74509064 P1104 Q74509064-5E332DF0-B2B1-496F-99E2-BD6A55FDBB0E @default.
- Q74509064 P1433 Q74509064-55F61485-84CC-453E-A4BF-93917C4387FE @default.
- Q74509064 P1476 Q74509064-FC439F4E-EA1E-4733-B3A3-99ED653A2446 @default.
- Q74509064 P2093 Q74509064-31A8CFF0-159B-47B5-8BAD-3B976CEB784E @default.
- Q74509064 P2093 Q74509064-34C8D200-FA0E-4289-98BF-25817B51C0AF @default.
- Q74509064 P2093 Q74509064-50AC19B7-FAD6-4172-8F9B-4443CEDC5626 @default.
- Q74509064 P2093 Q74509064-843E9C17-C7D3-4947-9F4B-1FBEE30AE723 @default.
- Q74509064 P2093 Q74509064-946C796C-D4B1-45AC-9756-CD4D6A08B167 @default.
- Q74509064 P304 Q74509064-7E1F7D1D-7469-4D53-AE86-A448C0DD1ADB @default.
- Q74509064 P31 Q74509064-E46A293A-0DF9-4E11-A6CF-A449E7C4EE57 @default.
- Q74509064 P433 Q74509064-A7A2C4F5-9101-4FD8-8AF4-6DB65A6811DE @default.
- Q74509064 P478 Q74509064-CB75B527-527A-44BB-9840-EAB1BE99D12A @default.
- Q74509064 P577 Q74509064-58234F2B-C886-4B01-85B8-D0CE42118F33 @default.
- Q74509064 P698 Q74509064-BEFD1C1C-C4A0-4E83-9628-37B2C5CD2B56 @default.
- Q74509064 P698 9571963 @default.
- Q74509064 P1104 "+8" @default.
- Q74509064 P1433 Q27709096 @default.
- Q74509064 P1476 "[Development of anti-cancer drugs under new renewed GCP--from the viewpoint of drug development company developer]" @default.
- Q74509064 P2093 "Inoue K" @default.
- Q74509064 P2093 "Kobayashi T" @default.
- Q74509064 P2093 "Ueno T" @default.
- Q74509064 P2093 "Yamada Y" @default.
- Q74509064 P2093 "Yanagi Y" @default.
- Q74509064 P304 "663-670" @default.
- Q74509064 P31 Q13442814 @default.
- Q74509064 P433 "5" @default.
- Q74509064 P478 "25" @default.
- Q74509064 P577 "1998-04-01T00:00:00Z" @default.
- Q74509064 P698 "9571963" @default.